Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

GlycoMimetics Inc

GLYC
0,2712
0,00 (0,00%)
26 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/2/202523:00EDGAR2Form 425 - Prospectuses and communications, business..
25/2/202523:00EDGAR2Form 8-K - Current report
18/2/202523:13EDGAR2Form S-4 - Registration of securities, business combinations
15/2/202500:38EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/2/202522:35EDGAR2Form 425 - Prospectuses and communications, business..
14/2/202522:35EDGAR2Form 8-K - Current report
13/2/202522:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
31/1/202523:00EDGAR2Form 8-K - Current report
13/1/202515:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/1/202515:00EDGAR2Form 8-K - Current report
26/12/202422:30EDGAR2Form 8-K - Current report
27/11/202420:22EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
12/11/202414:00PRNUSCrescent Biopharma to Present at Jefferies London Healthcare..
07/11/202422:47EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/11/202422:42EDGAR2Form 8-K - Current report
06/11/202423:41EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
06/11/202413:00BWGlycoMimetics Announces New Uproleselan Clinical Data Will..
04/11/202422:26EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
04/11/202420:01EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
29/10/202415:00APSBiotech Up Over +100% Premarket Following Merger And Funding..
29/10/202413:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/10/202413:09EDGAR2Form 8-K - Current report
29/10/202412:00BWGlycoMimetics Enters Into Acquisition Agreement With..
29/10/202411:30BWGlycoMimetics Announces National Cancer Institute Phase 2/3..
15/8/202423:01EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/8/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/7/202421:55EDGAR2Form 8-K - Current report
30/7/202401:24EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
25/7/202415:00BWGlycoMimetics Announces Strategic Review and Corporate..
13/6/202422:30EDGAR2Form 8-K - Current report
04/6/202415:30EDGAR2Form 8-K - Current report
04/6/202413:00BWGlycoMimetics Announces Comprehensive Results from Pivotal..
29/5/202422:01BWGlycoMimetics to Host Key Opinion Leader Event to Review..
09/5/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:01EDGAR2Form 8-K - Current report
06/5/202412:00BWGlycoMimetics Announces Results of Pivotal Phase 3 Study of..
25/4/202413:00BWGlycoMimetics to Report First Quarter 2024 Financial Results..
27/3/202412:00BWGlycoMimetics Reports Highlights and Financial Results for..
13/3/202412:00BWGlycoMimetics to Report Fourth Quarter and 2023 Full Year..
01/3/202415:16EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 0,2712

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network